Shuterin Enhances the Cytotoxicity of the Natural Killer Leukemia Cell Line KHYG-1 by Increasing the Expression Levels of Granzyme B and IFN-γ through the MAPK and Ras/Raf Signaling Pathways

Int J Mol Sci. 2022 Oct 24;23(21):12816. doi: 10.3390/ijms232112816.

Abstract

Natural killer (NK) cell therapy is an emerging tool for cancer immunotherapy. NK cells are isolated from peripheral blood, and their number and activity are limited. Therefore, primary NK cells should be expanded substantially, and their proliferation and cytotoxicity must be enhanced. Shuterin is a phytochemical isolated from Ficus thonningii. In this study, we explored the possible capacity of shuterin to enhance the proliferation and activity of KHYG-1 cells (an NK leukemia cell line). Shuterin enhanced the proliferation of KHYG-1 cells and their cytotoxicity to K562 cells. Moreover, this phytochemical induced the expression of granzyme B by promoting the phosphorylated cyclic adenosine monophosphate response element-binding protein (CREB) and mitogen-activated protein kinase (MAPK) signaling pathways. Furthermore, the secretion of interferon (IFN)-γ increased with increasing levels of shuterin in KHYG-1 cells and NK cells obtained from adults with head and neck squamous cell carcinoma. Shuterin appeared to induce IFN-γ secretion by increasing the expression of lectin-like transcript 1 and the phosphorylation of proteins involved in the Ras/Raf pathway. Thus, shuterin represents a promising agent for promoting the proliferation and cytotoxicity of NK cells.

Keywords: HNSCC; INF-γ; MAPK pathway; natural killer cells; shuterin.

MeSH terms

  • Granzymes / metabolism
  • Humans
  • Interferon-gamma / metabolism
  • K562 Cells
  • Killer Cells, Natural / metabolism
  • Leukemia* / metabolism
  • Mitogen-Activated Protein Kinases* / metabolism
  • Signal Transduction

Substances

  • Granzymes
  • Interferon-gamma
  • Mitogen-Activated Protein Kinases
  • Shuterin

Grants and funding

This research received no external funding.